Anti-D prophylaxis benefits babies of RhD-negative pregnant women

07/1/2013 | Medscape (free registration)

Routine antenatal anti-D prophylaxis in pregnant women who are Rhesus D-negative during week 28 to 30 of pregnancy could help prevent hemolytic disease in their babies, according to a study published in Acta Obstetricia et Gynecologica Scandinavica. The retrospective review involved a cohort of all RhD-immunized pregnant women in Stockholm between 1990 and 2008. Researchers also said that first-trimester fetal RHD gene screening allows for selective administration of RAADP to RhD-negative women with an RHD-positive fetus.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY